STAA Stock Overview
Designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
STAAR Surgical Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$37.91 |
52 Week High | US$52.68 |
52 Week Low | US$26.66 |
Beta | 0.60 |
11 Month Change | -14.29% |
3 Month Change | -11.22% |
1 Year Change | -11.94% |
33 Year Change | -70.77% |
5 Year Change | 27.60% |
Change since IPO | 59.62% |
Recent News & Updates
Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing
Jul 12Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
May 27Recent updates
Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing
Jul 12Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
May 27Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher
Apr 26STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge
Apr 05STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue
Mar 25STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade
Mar 13STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump
Mar 07Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
Jan 31With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For
Jan 05Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
Nov 30Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?
Nov 12Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
Oct 25Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes
Aug 24Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?
Jul 02Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?
Jun 17Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
May 13A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Mar 26STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital
Mar 12Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?
Feb 13Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
Jan 28Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Dec 15The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising
Dec 01What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?
Oct 26Keep Adding To STAAR Surgical Longs, Buy Thesis Remains
Sep 20Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
Sep 05STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 21STAAR Surgical rises 15% on Q2 result beat
Aug 11Should You Think About Buying STAAR Surgical Company (NASDAQ:STAA) Now?
Jul 20STAAR Surgical: Hard Data Approach Justifies Long-Only Portfolio Allocation
Jul 05Shareholder Returns
STAA | US Medical Equipment | US Market | |
---|---|---|---|
7D | -1.2% | 2.7% | 3.9% |
1Y | -11.9% | 10.5% | 25.3% |
Return vs Industry: STAA underperformed the US Medical Equipment industry which returned 9.3% over the past year.
Return vs Market: STAA underperformed the US Market which returned 24.9% over the past year.
Price Volatility
STAA volatility | |
---|---|
STAA Average Weekly Movement | 8.0% |
Medical Equipment Industry Average Movement | 8.4% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.1% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: STAA's share price has been volatile over the past 3 months.
Volatility Over Time: STAA's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1982 | 1,057 | Tom Frinzi | www.staar.com |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
STAAR Surgical Company Fundamentals Summary
STAA fundamental statistics | |
---|---|
Market cap | US$1.79b |
Earnings (TTM) | US$16.61m |
Revenue (TTM) | US$332.94m |
112.2x
P/E Ratio5.6x
P/S RatioIs STAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
STAA income statement (TTM) | |
---|---|
Revenue | US$332.94m |
Cost of Revenue | US$69.13m |
Gross Profit | US$263.81m |
Other Expenses | US$247.20m |
Earnings | US$16.61m |
Last Reported Earnings
Jun 28, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.34 |
Gross Margin | 79.24% |
Net Profit Margin | 4.99% |
Debt/Equity Ratio | 0% |
How did STAA perform over the long term?
See historical performance and comparison